buildclinical.com

Product Overview

BuildClinical is a SaaS tool focused on clinical research. It has now merged with OpenClinica and been rebranded as OpenClinica Recruit. The platform is primarily designed to help academic researchers address participant recruitment challenges in clinical studies through technology and new data-driven methods, accelerating study enrollment. After the merger, it brings advanced recruitment services and powerful eClinical tools into a single ecosystem.

Core Dimension Analysis

• Core Function Modules: The product is centered on “clinical study recruitment,” using data-driven strategies to improve enrollment efficiency. Following its merger with OpenClinica, its functional scope has expanded, creating a closed loop from participant recruitment to eClinical data management.
• Plans and Pricing / Free Version and Trial: The publicly available information currently collected does not disclose any pricing tiers, free version, or trial details. It is likely that users need to contact the sales team for a custom quote.
• Third-Party Integrations / Team Collaboration / Data Security / Deployment Options / API Support: Specific information on these areas is not reflected in the page text. Given the strict data compliance requirements in clinical research, such as HIPAA and 21 CFR Part 11, the merged platform would be expected to have robust security and compliance mechanisms. However, there is currently a lack of public statements, and transparency is limited.

Pros, Cons, and Best-Fit Users

Pros: Deep focus on recruitment pain points in the academic research niche; integration of recruitment and clinical data management after the merger with OpenClinica; innovative data-driven recruitment approach.
Cons: The brand is still in a merger transition phase, so the product integration experience and stability remain to be seen; publicly available product details, technical specifications, and pricing on the official website are extremely limited, creating a high barrier for initial evaluation.
Best Fit: Academic researchers and clinical research organizations facing challenges with participant recruitment.

China Access and Alternatives

Regarding access from China, the text does not mention overseas deployment nodes. As an overseas enterprise SaaS product, direct access from mainland China may involve network latency, and the actual status is unknown. Payment methods are also not specified. For domestic users who require compliant, low-latency alternatives, local clinical trial management systems (CTMS) and participant recruitment platforms may be worth considering.